Weekly Piece of Future #179
From Brain-Controlled Robots to Quantum Teleportation and CRISPR Immune Commanders
Hey there, fellow future-addicts!
Welcome to this week's edition of Rushing Robotics! What a week. From brain-controlled robots to quantum teleportation outperforming classical transmission, the pace of innovation isn't just accelerating—it's feeding on itself. This week alone, we're watching open-source AI shatter parameter records, diamond-based quantum computers ship without cryogenics, and CRISPR reveal itself as something far more sophisticated than the precision scissor we once imagined.
🤯 Mind-Blowing
BrainCo launched a brain-to-robot AI platform that turns neural signals into robotic actions—affordable and commercially viable. Moonshot AI dropped Kimi K3, a 2.8-trillion-parameter open-source model beating OpenAI and Anthropic on coding benchmarks. Biren Technology unveiled optical "supernode" interconnects that blow past the 128-GPU copper limit. Researchers from Beijing Institute of Technology published a framework for autonomous microrobots navigating the human body for drug delivery. And the University of Science and Technology of China proved quantum teleportation beats direct photon transmission by nearly 3x in lossy channels—the first head-to-head test ever.
🔊 Industry Insights & Updates
The infrastructure layer is getting loud. MIT printed a 2.3-meter concrete bridge in 30 minutes that held over 2,000 pounds. AGIBOT launched four new robots at WAIC 2026—humanoids, industrial platforms, and a direct-drive manipulation system. SAXON Q shipped diamond-based quantum computers running at room temperature—128 and 512 qubits, no cryogenics, plugging into standard server racks. Bristol Myers Squibb deployed their second NVIDIA DGX SuperPOD, giving every scientist access to what used to be a small-team luxury. What required specialized facilities is becoming rack-mountable and accessible.
🧬 BioTech
CRISPR just got an upgrade in how we understand it. Prof. LI Ming's team discovered CRISPR-Cas doesn't just snip viruses—it commands a network of 20+ innate immune modules called "CRISIS." St. Jude researchers found sickle cell disease ages blood stem cells prematurely, starting as early as age 6, and senolytic drugs can reverse the damage. University of Virginia scientists developed a nanoparticle + focused ultrasound approach to deliver microRNAs through the blood-brain barrier to fight glioblastoma. Biology is being rewritten at the immune, cellular, and molecular levels simultaneously.
💡 Products/Tools of the Week
Four tools worth your attention. PolyTalk delivers open-source, self-hosted speech-to-speech translation across 30+ languages with sub-second latency—no cloud required. Scribe automatically extracts decisions and patterns from git repos and coding agent sessions into a searchable local knowledge base. Zro offers private inference for open-weight coding models like GLM-5.2 and MiniMax M3 with zero request retention. Script.it brings a scripting-agent approach to workflow automation that's easier to verify than traditional no-code platforms.
🎥 Video Section
Three drops worth your screen time. Unitree Robotics showcases real-time omni-modal interaction driving whole-body mobile manipulation. Mimic introduces the M1 hand, a new benchmark in dexterous manipulation hardware. And Generative Bionics delivers a six-month update on GENE.01, their bionic system coming to life.
We're watching a dozen different fields hit escape velocity at the same time. Room-temperature quantum computers, brain-controlled robotics, CRISPR acting as an immune commander, teleportation beating direct transmission—these aren't incremental updates. The frontier isn't just moving. It's multiplying. Stay hungry, stay futurish!
🤯 Mind-Blowing
A major step forward in neurotechnology has been taken with the launch of BrainCo's new brain-to-robot AI platform, announced by the Chinese startup this week. The platform allows users to control robotic systems using only their brain signals, processed through advanced AI algorithms that interpret neural patterns and convert them into robotic actions. BrainCo designed the system to be more user-friendly and affordable than previous brain-computer interfaces, opening possibilities for applications in prosthetics, industrial automation, and assistive technology. The company believes this launch represents a crucial milestone in making brain-controlled robotics commercially viable and accessible to a broader market.
A new world record for open-source AI has been set as Chinese start-up Moonshot AI unveiled Kimi K3, a model with 2.8 trillion parameters that surpasses all previous open-source offerings. The Beijing-based company said the model outperformed systems from OpenAI and Anthropic in certain evaluations, particularly in coding and software engineering tasks. Moonshot designed K3 for long-horizon coding, knowledge work, and reasoning tasks. The model will be available through Moonshot's Kimi chatbot and developer tools, with full weights released on July 27.
A new optical technology for linking AI chips has been unveiled by Chinese chip start-up Biren Technology at the World Artificial Intelligence Conference in Shanghai. The company's "supernode" solutions use near-packaged optics to connect up to 1,024 processor cards across a single cluster, bypassing the 128-GPU limit of traditional copper-wired systems. Biren developed this approach to compete with Nvidia's platforms as AI models grow to trillions of parameters. The Shanghai-based firm projects mass commercial roll-out of the optical technology by 2028.
A comprehensive review of autonomous microrobots for drug delivery has been published by researchers led by Professor Huaping Wang of the Beijing Institute of Technology, outlining how tiny robots can sense, navigate, and release drugs on demand inside the human body. The paper, published in Cyborg and Bionic Systems on June 29, 2026, introduces a four-tier hierarchy based on barrier traversal capability, ranging from local delivery in accessible cavities to immune-privileged sites like the brain. Co-authors Shihao Zhong, Anping Wu, Shanming Bai, Henwei Huang, Toshio Fukuda, and Huaping Wang describe how magnetic, acoustic, and biohybrid propulsion systems can transform passive drug carriers into active therapeutic robots, with early clinical entry likely through gastrointestinal, bladder, and eye applications.
Quantum teleportation has been proven to beat direct photon transmission in long-distance communication, thanks to new research from the University of Science and Technology of China. The research team, led by co-senior author Chaoyang Lu, created an all-optical method to generate entangled photon pairs that largely avoid the losses suffered when photons travel directly through communication channels. When tested through a channel with only about 1% transmission capacity, teleportation proved nearly three times more efficient than direct transmission, even with optimal quantum cloning applied. Published in Nature Physics, the study marks the first experimental head-to-head comparison between teleportation and direct photon sending, moving the elegant four-decade-old concept closer to practical use in quantum relays, repeaters, and connected quantum processors.
🔊 Industry Insights & Updates
A breakthrough in construction has been achieved as MIT researchers developed a framework that makes 3D-printed concrete structures more efficient and practical. The team designed and printed a 2.3-meter concrete bridge in just 30 minutes using off-the-shelf mortar, then load-tested it to hold more than 2,000 pounds with virtually no bending. Co-first authors Hajin Kim-Tackowiak and Zane Schemmer, working with senior author Josephine Carstensen, created a system that bakes printer limitations directly into the design optimization, generating fully printable designs in about two minutes on a laptop. The biggest surprise was that printer hardware, not concrete itself, limits efficiency. Their analysis revealed that a machine able to lay a 1-centimeter bead instead of the current 4 centimeters could reduce material use by 76 percent while staying within safety margins. The research, published in Additive Manufacturing and funded by the National Science Foundation, provides a roadmap for printer-makers to unlock large gains in efficiency.
Four new robotics products have been unveiled by AGIBOT at the World Artificial Intelligence Conference 2026 in Shanghai, expanding its portfolio across humanoid platforms, industrial robots, and dexterous manipulation systems. The launches include the A3 Ultra full-size humanoid robot, X2 Edu, G2 Max heavy-payload industrial robot, and OmniHand 3 Ultra-M direct-drive manipulation system. More than 30 AGIBOT robots are operating across WAIC venues, providing visitor guidance and on-site support. Peng Zhihui, Co-founder, President and CTO of AGIBOT, said the industry should judge embodied AI by whether robots can be reliably integrated into real operating environments, not by one-time demonstrations.
A new line of diamond-based quantum computers operating at room temperature has been launched by German start-up SAXON Q, marking the first time nitrogen-vacancy center processors have exceeded ten physical qubits. The company released two models, the SXQ128 with 128 qubits and the SXQ512 with 512 qubits, both designed to fit into standard server racks and run on ordinary AC wall outlets without cryogenic cooling or vacuum systems. Spun out of Leipzig University and led by CEO Prof. Dr. Marius Grundmann and CTO Prof. Dr. Jan-Berend Meijer, SAXON Q solved a long-standing manufacturing bottleneck through a proprietary sulfur co-implantation process that achieves over 85 percent conversion yield, far surpassing traditional rates of 1 to 10 percent. The SXQ128 is available to order immediately with deliveries starting late summer 2026, while the SXQ512 ships in Q2 2027.
A second NVIDIA DGX SuperPOD has been deployed by Bristol Myers Squibb, built on eight DGX Vera Rubin NVL72 systems that the company calls the most powerful and energy-efficient AI cluster in life sciences. The new system delivers up to 10x the performance per megawatt of the infrastructure it replaces, giving every BMS scientist access to a unified AI platform rather than just a small group of researchers. Erin Davis, vice president of research business insights and technology at BMS, said the system opens up limitless compute to all scientists, enabling faster drug discovery cycles across the full pipeline.
🧬 BioTech
A breakthrough in understanding bacterial immunity has been achieved as researchers revealed CRISPR-Cas does far more than act as a lone sniper against viruses. Prof. LI Ming from the Institute of Microbiology of the Chinese Academy of Sciences led a study showing that CRISPR-Cas serves as a commander that orchestrates a network of innate immune systems. The team discovered more than 20 innate defense modules embedded within type I CRISPR-Cas loci, controlled by small crRNA-like RNAs that guide CRISPR machinery without triggering DNA cleavage. These CRISPR-supervised systems, termed “CRISIS,” are kept in check when CRISPR is active to avoid fitness costs. However, when phages deploy anti-CRISPR proteins to suppress CRISPR, the brakes are released and CRISIS systems unleash innate immunity. Published in Nature on July 22, 2026, the findings reshape the view of bacterial defense.
A new study has revealed that sickle cell disease causes premature aging of blood stem cells, a problem that may be reversible with anti-aging drugs. Researchers at St. Jude Children's Research Hospital found that blood stem cells from young patients as early as 6 years old showed markers of senescence, making them less capable of producing healthy blood cells. When the team treated mice implanted with patient stem cells using senolytic drugs, the damaged cells were eliminated and blood-forming potential was restored. The study, published in Science Translational Medicine on July 22, 2026, was led by senior co-corresponding author Shannon McKinney-Freeman, first author Aditya Barve, and co-corresponding author Akshay Sharma, who believe the findings could improve both stem cell collection and outcomes for sickle cell gene therapy.
A new experimental approach to targeting glioblastoma, the deadliest brain cancer, has been developed by scientists at the University of Virginia Comprehensive Cancer Center. The team, led by Roger Abounader, MD, PhD, identified microRNAs that can simultaneously suppress multiple malfunctioning genes responsible for the tumor's formation and growth. The researchers use brain-penetrating nanoparticles, focused ultrasound waves, and microbubbles to deliver the miRNAs through the blood-brain barrier, which typically blocks treatments from reaching the brain. Lab testing showed the approach slowed tumor growth and extended survival in animal models. The findings were published in the Journal of Clinical Investigation.
💡Products/tools of the week
Live audio translation now runs entirely on your own infrastructure with sub-second latency. PolyTalk created this open-source, self-hosted speech-to-speech platform supporting over 30 languages. It works with microphones, browser tabs, meetings, and audio streams without sending data to external cloud services. The platform comes in a free Community Edition and a paid Enterprise Workspace edition, both fully on-premise. PolyTalk built it for healthcare, government, legal, education, and other fields needing private multilingual communication
Extracting decisions, patterns, and learnings from git repositories, Claude Code and Codex sessions, and self-sent links into a curated, semantically searchable markdown knowledge base can now happen automatically. Scribe developed this single-binary CLI that runs on a cron schedule and works fully local, with no external vector database or hosted infrastructure required. The tool uses BM25 full-text search over auto-generated wiki files, ensuring lookups stay fast and cheap. Scribe integrated it with AI coding agents like Claude Code and Codex by writing a handshake block into their config files, enabling every agent session to query the knowledge base before making architectural or library recommendations.
Open-weight coding models can now run through a private inference endpoint with zero request retention and no training on customer data. Zro built this endpoint to support popular coding agents including Claude Code, Codex CLI, Cursor, Cline, and others via an npm package and OpenAI- or Anthropic-compatible APIs. The platform is optimized for long-context, multi-turn coding sessions using HyperQuant compression and custom attention kernels on AMD, NVIDIA, and TPU hardware. Zro currently offers MiniMax M3 and GLM-5.2, with additional open-weight models planned. Billing starts at $20 per month for $60 of inference spend, and Zro also offers pay-as-you-go usage packs.
A new AI-powered automation platform now lets users build reliable, verifiable workflows using a scripting agent approach. Script.it developed this platform to be easier to build and verify than traditional no-code tools like n8n, Zapier, or Make, along with visual workflow builders and black-box AI agents. Users can define structured scripts with inputs, steps, and integrations that run automatically or on a schedule. Script.it also supports human-in-the-loop and agent-in-the-loop patterns, making it suitable for recurring tasks such as data gathering, digest compilation, and email delivery.
